Teva Pharmaceutical Industries

Filed a patent for "multiparticulate dosage forms comprising deutetrabenazine" on Thu, March 14, 2024

Filed a patent for "solid state forms of mavacamten and process for preparation thereof" on Thu, July 11, 2024

Filed a patent for "solid state forms of deucravacitinib, deucravacitinib hcl and process for preparation thereof" on Tue, July 5, 2022

Filed a patent for "inhaler system" on Thu, November 3, 2022

Filed a patent for "solid state forms of mavacamten and process for preparation thereof" on Thu, February 23, 2023

Filed a patent for "solid state forms of lx9211 and salts thereof" on Tue, July 26, 2022

Filed a patent for "solid state forms of lx9211 and salts thereof" on Thu, September 15, 2022

Filed a patent for "solid state forms of tolebrutinib and of tolebrutinib salts" on Thu, October 6, 2022

Filed a patent for "process and intermediates for preparation of deucravacitinib and salts thereof" on Mon, October 24, 2022

Filed a patent for "injection spring for aged prefilled syringe and auto injector" on Thu, May 25, 2023

Filed a patent for "process for preparation of avacopan and intermediates thereof" on Tue, January 17, 2023

Filed a patent for "treating refractory migraine" on Thu, August 3, 2023

Filed a patent for "multiparticulate dosage forms comprising deutetrabenazine" on Thu, November 16, 2023

Filed a patent for "gastro retentive dosage forms comprising deutetrabenazine" on Thu, December 7, 2023

Filed a patent for "antagonist antibodies directed against calcitonin gene-related peptide and methods using same" on Thu, May 16, 2024

Filed a patent for "solid state forms of lumateperone ditosylate salt" on Thu, November 30, 2023

Filed a patent for "pre-filled syringe" on Thu, February 8, 2024

Filed a patent for "modified release formulations of pridopidine" on Thu, February 8, 2024

Filed a patent for "solid state forms of tolebrutinib and of tolebrutinib salts" on Thu, March 31, 2022

Filed a patent for "antagonist antibodies directed against calcitonin gene-related peptide and methods using same" on Thu, July 27, 2023

Filed a patent for "solid state forms of tolebrutinib and of tolebrutinib salts" on Fri, July 22, 2022